These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8650412)

  • 1. [Therapeutic role of coagulation in small cell lung cancers].
    LeBeau B
    Rev Mal Respir; 1996; 13(1):21-6. PubMed ID: 8650412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy in patients with small cell lung cancer. Part I. Influence of AD on the haemostatic system].
    Ochmański W
    Przegl Lek; 2008; 65(6):288-98. PubMed ID: 18853660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy of small cell lung cancer. Part II. Influence of treatment on time of remission and patients survival].
    Ochmański W
    Przegl Lek; 2008; 65(7-8):321-8. PubMed ID: 19004228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is there progress in the chemotherapy of small cell lung cancer?].
    Calderoni A; Cerny T; Betticher DC
    Schweiz Med Wochenschr; 1999 Sep; 129(37):1313-20. PubMed ID: 10515004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
    Sculier JP; Paesmans M; Lecomte J; Van Cutsem O; Lafitte JJ; Berghmans T; Koumakis G; Florin MC; Thiriaux J; Michel J; Giner V; Berchier MC; Mommen P; Ninane V; Klastersky J;
    Br J Cancer; 2001 Nov; 85(10):1444-51. PubMed ID: 11720426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coagulation and bronchopulmonary cancers: from clinical aspects to biology].
    Brechot JM; Conard J; Samama M
    Rev Mal Respir; 1992; 9(4):375-84. PubMed ID: 1324514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation].
    Fietkau R; Sauer R
    Strahlenther Onkol; 2002 Nov; 178(11):585-8. PubMed ID: 12518770
    [No Abstract]   [Full Text] [Related]  

  • 8. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemotherapy for lung cancer].
    Hara N; Ohta M; Motohiro A; Takeo S; Miyake J; Ohtsu Y; Yamazaki S
    Rinsho Kyobu Geka; 1987; 7(5):444-7. PubMed ID: 9301797
    [No Abstract]   [Full Text] [Related]  

  • 11. [Small cell lung cancer: therapeutic standard and prospects].
    Wolf M
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S20-4S26. PubMed ID: 15687989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgical treatment for small cell lung cancer].
    Saito Y; Kanma K; Sagawa M; Sato M; Takahashi S; Usuda K; Fujimura S
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():390-7. PubMed ID: 9369913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
    Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L
    Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
    Yamamoto N; Tamura T; Fukuoka M; Saijo N
    Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
    Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
    Rudin CM; Kozloff M; Hoffman PC; Edelman MJ; Karnauskas R; Tomek R; Szeto L; Vokes EE
    J Clin Oncol; 2004 Mar; 22(6):1110-7. PubMed ID: 15020613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Search for the "optimal" dose of antithrombotic agents].
    Mismetti P; Laporte-Simitsidis S; Decousus H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1473-7. PubMed ID: 9092405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
    Bozcuk H; Artac M; Ozdogan M; Savas B
    Cancer; 2005 Dec; 104(12):2650-7. PubMed ID: 16284984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.